Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
Transcatheter PVL closure vs. surgery | Medtronic DCB gains FDA approval
Tuesday, May 31, 2022
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

Transcatheter PVL closure linked to lower 30-day mortality than surgery

Long-term mortality, meanwhile, is similar between the two treatment options.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Transcatheter PVL closure linked to lower 30-day mortality than surgery

Share on Twitter Share on Facebook Share on Linkedin
Long-term mortality, meanwhile, is similar between the two treatment options.
READ MORE >

Medtronic gains FDA approval for new DCB compatible with 0.018” guidewires

The drug-coated balloon was approved to treat patients with peripheral arterial disease (PAD) in the superficial femoral and popliteal arteries

READ MORE >
Medtronic has received FDA approval for its IN.PACT 018 Paclitaxel-Coated Percutaneous Transluminal Angioplasty (PTA) Balloon Catheter. FDA clears new drug eluting balloon, drug-coated balloon.
Share on Twitter Share on Facebook Share on Linkedin

Medtronic gains FDA approval for new DCB compatible with 0.018” guidewires

Share on Twitter Share on Facebook Share on Linkedin
Medtronic has received FDA approval for its IN.PACT 018 Paclitaxel-Coated Percutaneous Transluminal Angioplasty (PTA) Balloon Catheter. FDA clears new drug eluting balloon, drug-coated balloon.
The drug-coated balloon was approved to treat patients with peripheral arterial disease (PAD) in the superficial femoral and popliteal arteries
READ MORE >

Featured Articles

FDA announces Class I recall of 4,800 imaging catheters due to risk of vascular injury

There have been five reported incidents so far, including one patient injury.

READ MORE >
Dragonfly OpStar Imaging Catheter FDA recall May 2022
Share on Twitter Share on Facebook Share on Linkedin

FDA announces Class I recall of 4,800 imaging catheters due to risk of vascular injury

Share on Twitter Share on Facebook Share on Linkedin
Dragonfly OpStar Imaging Catheter FDA recall May 2022
There have been five reported incidents so far, including one patient injury.
READ MORE >

Open AAA repair linked to better long-term outcomes than EVAR

However, the authors noted, 30-day survival is significantly higher after EVAR than open AAA repair.  

READ MORE >
Abdominal aortic aneurysm (AAA)
Share on Twitter Share on Facebook Share on Linkedin

Open AAA repair linked to better long-term outcomes than EVAR

Share on Twitter Share on Facebook Share on Linkedin
Abdominal aortic aneurysm (AAA)
However, the authors noted, 30-day survival is significantly higher after EVAR than open AAA repair.  
READ MORE >

A new use for metformin? Popular type 2 diabetes medication may also improve cancer and infection therapies

Metformin appears to improve the impact of chemodynamic therapy, according to a new analysis in Nano Research. 

READ MORE >
metformin chemodynamic therapy type 2 diabetes Nano Research
Share on Twitter Share on Facebook Share on Linkedin

A new use for metformin? Popular type 2 diabetes medication may also improve cancer and infection therapies

Share on Twitter Share on Facebook Share on Linkedin
metformin chemodynamic therapy type 2 diabetes Nano Research
Metformin appears to improve the impact of chemodynamic therapy, according to a new analysis in Nano Research. 
READ MORE >

In Case You Missed It

TPV valves, CTO PCI and more: SCAI 2022 updates for interventional cardiologists

The first two days of SCAI 2022 were jam-packed with innovative technologies and late-breaking research.

READ MORE >
SCAI 2022 interventional cardiology TAVR CTO PCI TPV cath labs
Share on Twitter Share on Facebook Share on Linkedin

TPV valves, CTO PCI and more: SCAI 2022 updates for interventional cardiologists

Share on Twitter Share on Facebook Share on Linkedin
SCAI 2022 interventional cardiology TAVR CTO PCI TPV cath labs
The first two days of SCAI 2022 were jam-packed with innovative technologies and late-breaking research.
READ MORE >

Cusp overlap technique, optimized treatment strategy tied to significant improvements for TAVR patients

The research, presented at EuroPCR 2022 in Paris, represented an updated look at the Optimize PRO study, an ongoing analysis of patients treated with Medtronic’s self-expanding Evolut Pro and Pro+ TAVR systems.

READ MORE >
Transcatheter aortic valve replacement (TAVR) patients continue to benefit from an optimized pre- and post-procedural treatment strategy that utilizes the cusp overlap technique and the Evolut Pro and Pro+ TAVR valves, according to new findings presented at EuroPCR 2022 in Paris.
Share on Twitter Share on Facebook Share on Linkedin

Cusp overlap technique, optimized treatment strategy tied to significant improvements for TAVR patients

Share on Twitter Share on Facebook Share on Linkedin
Transcatheter aortic valve replacement (TAVR) patients continue to benefit from an optimized pre- and post-procedural treatment strategy that utilizes the cusp overlap technique and the Evolut Pro and Pro+ TAVR valves, according to new findings presented at EuroPCR 2022 in Paris.
The research, presented at EuroPCR 2022 in Paris, represented an updated look at the Optimize PRO study, an ongoing analysis of patients treated with Medtronic’s self-expanding Evolut Pro and Pro+ TAVR systems.
READ MORE >

In Other News

Parents welcome AI in pediatric emergency departments, but some uncertainty remains

Family engagement is seen as critical for the implementation of AI-based clinical decision support tools in pediatrics, which the authors of this study say will play an increasing role in healthcare.

READ MORE >
A survey conducted by the Ann and Robert H. Lurie Children's Hospital of Chicago found more than 75% of parents are generally receptive to the use of artificial intelligence (AI) tools in the management of children with respiratory illnesses in the emergency department (ED). However, some demographic subgroups, including non-Hispanic black and younger age parents, had greater reservations about the use of these technologies. 
Share on Twitter Share on Facebook Share on Linkedin

Parents welcome AI in pediatric emergency departments, but some uncertainty remains

Share on Twitter Share on Facebook Share on Linkedin
A survey conducted by the Ann and Robert H. Lurie Children's Hospital of Chicago found more than 75% of parents are generally receptive to the use of artificial intelligence (AI) tools in the management of children with respiratory illnesses in the emergency department (ED). However, some demographic subgroups, including non-Hispanic black and younger age parents, had greater reservations about the use of these technologies. 
Family engagement is seen as critical for the implementation of AI-based clinical decision support tools in pediatrics, which the authors of this study say will play an increasing role in healthcare.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Medtech giant makes big move | The world’s top hospitals for heart surgery | New CPT codes | PET vs. SPECT | TAVR tech recalled
AI is gaining ground, but clinicians run the show | Siemens Healthineers doubles down | Electrophysiologist compensation
News Alert: FDA shares warning about heart valve tech after patient death
Cardiologist pay & productivity are up | FDA clears PE thrombectomy devices | Cardiology tech in spotlight | Gore's new approval
Cardiology salaries on the rise | The climbing costs of care | M&A trends | Siemens Healthineers, J&J make big business moves
Major MRI trends | Blood thinner recalled | When to perform PCI before TAVR | How to build a CCTA program | Steroids & the heart
CMS boosts coverage for heart failure tech | FDA approves CardioMEMS updates | LVADs linked to strokes, other risks
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme